Schrodinger Inc
NASDAQ:SDGR
Schrodinger Inc
Capital Expenditures
Schrodinger Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Schrodinger Inc
NASDAQ:SDGR
|
Capital Expenditures
-$13.9m
|
CAGR 3-Years
-85%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Capital Expenditures
-$26.2m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-24%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Capital Expenditures
-$31.6m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
-127%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Capital Expenditures
-$25m
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Capital Expenditures
-$6.2m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Capital Expenditures
-$55.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
See Also
What is Schrodinger Inc's Capital Expenditures?
Capital Expenditures
-13.9m
USD
Based on the financial report for Mar 31, 2024, Schrodinger Inc's Capital Expenditures amounts to -13.9m USD.
What is Schrodinger Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-17%
Over the last year, the Capital Expenditures growth was -41%. The average annual Capital Expenditures growth rates for Schrodinger Inc have been -85% over the past three years , -17% over the past five years .